P3 Health Partners (PIII) Reaffirms 2023 Guidance, Issues 2024 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
January 9, 2024 7:29 PM ESTHENDERSON, Nev.--(BUSINESS WIRE)-- P3 Health Partners Inc. (P3 or the Company) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is participating in J.P. Morgans 42nd Annual Healthcare Conference, being held in San Francisco, CA from January 8-11, 2024. In advance of the associated meetings and presentation, P3 is reaffirming guidance for 2023 and... More
